Tiba Biotech

RNA Vaccine Delivery Platform

Tiba Biotech is developing next-generation RNA vaccines and therapeutics that use their novel delivery system. Most RNA therapies today rely on decade’s old technology such as lipid nanoparticles to enable administration into the human body. Tiba’s approach employs their fully biodegradable nanoparticle delivery platform along with their computational RNA design for safer and more potent vaccines and therapeutics. While with an initial focus on COVID-19, Tiba is developing a range of novel vaccines to tackle the persistent challenge of seasonal influenza and emerging zoonotic threats.